In these studies there was evidence of lower SERT binding in the midbrain in DLB patients (Roselli et al., 2010), and higher SERT binding in the hypothalamus in PD patients compared with other forms of degenerative parkinsonism (Joling et al., 2017). This evidence concerns the gene SLC6A4 and Parkinson disease.